Atara Biotherapeutics resubmits tab-cel application to FDA

Go back to Atara Biotherapeutics resubmits tab-cel application to FDA
(NASDAQ: ATRA) Delayed: 8.35 -0.24 (2.79%)
Previous Close $8.59    52 Week High $40.80 
Open $8.68    52 Week Low $12.45 
Day High $8.68    P/E N/A 
Day Low $8.10    EPS $0.00 
Volume 35,268